Broad Patent Claims Come Before the Supreme Court in Amgen v Sanofi.

Tu, S Sean; Nagar, Sarosh; Van de Wiele, Victor L

Tu, S Sean; Nagar, Sarosh; Van de Wiele, Victor L.

Afiliação

Tu SS; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Nagar S; West Virginia University College of Law, Morgantown.
Van de Wiele VL; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

JAMA ; 329(19): 1641-1642, 2023 05 16.

Article em En | MEDLINE | ID: mdl-36972066

This Viewpoint discusses a current Supreme Court lawsuit, Amgen v Sanofi, involving Amgen's broad patents on PCSK9 that could effectively prevent other manufacturers from producing similar or even clinically superior antibodies, with important negative consequences for patients.

Assuntos

Patentes como Assunto; Decisões da Suprema Corte; Estados Unidos; Patentes como Assunto/legislação & jurisprudência

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Patentes como Assunto / Decisões da Suprema Corte Tipo de estudo: Prognostic_studies País/Região como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google